Award for Independent Research – What it means to me

0

Dr Rajesh ShahI wish to share some thoughts on how I look at having received an award from the Ministry of AYUSH, from the hands of honourable Vice President of India. (I don’t look at it as any personal achievement.)

 

 

1. This recognised the efforts of an independent researcher not working full time at any institution, university or college, but a clinician conceptualising and coordinating the research with several institutions. I’m not a scientist but a researcher, a full time clinician.

 

This appreciation should encourage many more scientific-minded clinicians to explore research in collaboration with other institutions.

 

2. This award is for New Drug Research in developing Mycobacterium Tuberculosis Nosode. This is a big thing for many reasons. This marks the scientific-revisiting of Nosodes using the modern technology.

 

3. This is first ever new Nosode ever developed systematically in the world in last 50 years.

 

4. This is the first major new homeopathic drug ever developed in India.

 

5. Indian government and the profession have finally recognised the importance of New Drug Research, that too in the Nosode category.

 

6. The Nosode was developed at highly reputed Government body, Haffkin Institute, which also makes BCG vaccine. That means, the Conventional medical research body has helped making the Homeopathic Nosode. This is historical.

 

7. Many more Nosodes can be expected bringing a revolution.

8. This new Nosode is one of the series of several, namely HIV Nosode, Hepatitis C Nosode, Malaria Nosode, Cancer Nosode, and more.

 

9. The recognition has opened doors to the era of new Nosodes, from India.

 

10. This research is for revamping the existing Tuberculinum Nosode, also recognising the need for remaking all other existing Nosodes.

 

11. This step will also facilitate further setting up the regulation for New Drug Development in India, for which I’m striving for over a decade.

 

12. This will hopefully encourage more research by researchers, scientists, institutions, pharmaceuticals, and clinicians in many parts of the world.

 

Honestly, this award, is not a sign of any personal achievement to me. More importantly, I’m looking at it as a mark of beginning of recognising the need for New Drug Research in Homeopathy. My dream is to have a wide range of new Nosodes scientifically processed, researched, introduced and brought formally to the medical profession benefitting millions of patients now and in future.

 

(My sincere thanks to various scientists, institutions, coinvestigators, ethical board, technicians, and colleagues who contributed in the work.)

 

Related links:

  1. https://www.sciencedirect.com/science/article/pii/S1475491616000175
  2. http://www.ijrh.org/article.asp?issn=09747168;year=2014;volume=8;issue=3;spage=166;epage=174;aulast=Shah
  3. https://m.timesofindia.com/city/mumbai/Haffkine-comes-up-with-homeo-drug-for-TB/amp_articleshow/46648115.cms
  4. http://www.ijrh.org/article.asp?issn=0974-7168;year=2017;volume=11;issue=3;spage=203;epage=205;aulast=Shah
  5. https://www.ncbi.nlm.nih.gov/m/pubmed/23870381/

 

 

Share.

About Author

Rajesh Shah (born January 18, 1963) is a practicing homeopath in Mumbai, India. He was one of the first to start online medical practice in India in 1995. He has conducted clinical trials using conventional research methods for HIV and Hepatitis C, using the respective nosodes, and concluded that high dilution, potentised homeopathic preparation from HIV virus could increase CD4 cells and reduce viral load in the responder group. In the Homeopathic Pathogenetic Trial of the alkaloids Capsaicin and Dihydrocapsaicin, the interesting finding was that about 40% of the healthy volunteers produced symptoms pertaining to pain, with high-dilution, potentised medicine from the source materials which has known capacity to produce pain in crude form. He has revamped the method of preparation and introduced a new nosode sourced from Mycobacterium Tuberculosis. This study prepared a nosode at the Haffkine Institute, sourced from four strains of the organisms, including Multidrug resistance Tuberculosis. The nosode sourced from Hepatitis C virus produced anti-cancer effect on cell lines in a laboratory model.The research demonstrated that a nosode showed anti-cancer effect. By using advanced imaging techniques, research showed that the drug triggered the death of cancer cells through apoptosis, a process of controlled cell death, by decreasing two cancer related enzymes called telomerase and topoisomerase II in the liver cells. Rajesh Shah is Secretary of the Global Homeopathy Foundation, an NGO working for the promotion of homeopathy. He identified the need for a change in regulation in India in the Nosode category, responsible for lack of scientific research for new drug discovery. For getting the required regulation updated, and for creating awareness among the homeopaths, he initiated a petition to the Minister of AYUSH (Govt of India) for corrective measures. Preclinical evaluation of anti-arthritic activity of ultra-diluted preparations of capsaicin alkaloids (CP-10), tumor necrosis factor-α, and Magnesium phosphoricum was conducted on Wistar rats which concluded that ultra-diluted preparations exhibited definite anti-arthritic activity, demonstrated in his research at leading institution. In a prominent research, he and his team have demonstrated anti-malarial activity of selected homeopathic medicines in cell line model. Three homeopathic preparations including the very first homeopathic medicine China officinalis and one of the latest medicines Plasmodium falciparum nosode have shown disease modifying properties in an in-vitro model by inhibition of hemozoin (beta Hematin) formation. Hemozoin formation is a validated target for most known antimalarial drugs today. Another research has demonstrated stimulation of melanin with homeopathic medicines in cell line model, at leading BYL Nair Hospital’s department of Clinical Pharmacology, Mumbai.

Leave A Reply